These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Hypophyseal reaction state during oral contraceptiva (author's transl)].
    Author: Gitsch E, Schneider WH, Schmid R, Spona J.
    Journal: Wien Klin Wochenschr; 1981 Oct 16; 93(19):599-601. PubMed ID: 6798764.
    Abstract:
    In 5 normocyclic women, firstly taking a conventional oral contraceptive, Neogynon (50 mcg EE + 250 mcg levo-norgestrel) for 6 months, the levels of LH, 17 beta-E2 and progesterone did not rise after changeover to a dose-reduced pill, Microgynon 30 (30 mcg EE + 150 mcg levo-norgestrel). This fact indicates maintained central suppression. Examination of the hypothalamic-hypophyseal axis by the Gn-RH test (50 mcg) with Microgynon 30 showed negative results during the first treatment cycle in 13 out of 18 women. In the 6th treatment cycle only 7 Gn-RH non-reactive women were observed and after stimulation with 100 mcg Gn-RH only 5 women remained with negative Gn-RH tests. Of the 20 women who took conventional oral contraceptives over a period of 6 months to 6 years (7 took Eugynon: 50 mcg EE + 500 mcg D,L-norgestrel, 5 Lyndiol: 75 mcg mestranol + 2.5 mg lynoestrenol, 8 Neogynon, only one from the Neogynon group showed a positive result. On the other hand there was a positive reaction in 4 out of 7 women using the two step dose-reduced preparation Sequilar (11 tablets of 50 mcg EE + 50 mct levo-norgestrel and 10 tablets of 50 mcg EE + 125 mcg levo-norgestrel). In 5 normocyclic women taking the oral contraceptive (OC) Neogynon (50 mcg ethinyl estradiol [EE] + 250 mcg levonorgestrel), the levels of LH, 17beta-estradiol 2, and progesterone did not rise after changeover to a dose-reduced pill Microgynon 30 (30 mcg EE + 150 mcg levonorgestrel). This fact indicates maintained central suppression. Examination of the hypothalamic-hypophyseal axis by the Gn-RH test (50 mcg) with Microgynon 30 showed negative results during the 1st treatment cycle in 13 of 18 women. In the 6th treatment cycle, only 7 Gn-RH nonreactive women were observed, and after stimulation with 100 mcg Gn-RH, only 5 women remained with negative Gn-RH tests. Of the 20 women who took conventional OCs over a period of 6 months-6 years (7 took Eugynon--50 mcg EE + 500 mcg D'L norgestrel; 5 Lyndiol--75 mcg mestranol + 2.5 mg lynestrenol; 8 Neogynon). Only 1 from the Neogynon showed a positive result. On the other hand, there was a positive reaction in 4 of 7 women using the 2-step dose-reduced preparation Sequilar (11 tablets of 50 mcg EE + 50 mcg levonorgestrel and 10 tablets of 50 mcg EE + 125 mcg levonorgestrel. Our results suggest that preparations with reduced steroid content influence hypophyseal function to a lesser extent, while simultaneously maintaining hypothalamic suppression, than conventional combinations of steroids do. (author's)
    [Abstract] [Full Text] [Related] [New Search]